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ABSTRACT
Objectives: To estimate indirect costs through human capital
approach and intangible costs through willingness-to-pay
(WTP), and identify factors potentially affecting these costs
in multiethnic Asian patients with knee osteoarthritis (OA).
Methods: Datawere collected through face-to-face interviews
among knee OA patients. Human capital approach was used
to estimate indirect costs by multiplying: 1) days of absence
from work because of OA, with average earnings per capita
per day for working patients; or 2) productivity loss with the
market price of housekeeping for retirees/homemakers. A
closed-ended iterative bidding contingent valuation method
was used to elicit willingness-to-pay for a hypothetical cure of
OA as a proxy for intangible costs. Mann–Whitney U or
Kruskal–Wallis H-tests were performed in univariate ana-
lyzes, and linear regression in multivariate analyses.
Results: Indirect costs per year and intangible costs were
estimated at US$1008 and US$1200, accounting for 2.8%
and 3.3% of annual household income, respectively. The
indirect costs were signiﬁcantly higher for male or working
patients, while intangible costs were higher for Chinese,
working patients, with higher income, or worse global
well-being.
Conclusion: This study demonstrated that eliciting indirect
costs through human capital approach and intangible costs
through WTP are acceptable and feasible in Asian patients
with knee OA. Besides the direct costs, the indirect and
intangible costs for the OA patients could be substantial.
Keywords: human capital approach, indirect costs, Intangible
costs, knee, osteoarthritis, willingness-to-pay.
Introduction
Osteoarthritis (OA) is one of the commonest chronic
diseases worldwide and imposes a substantial eco-
nomic burden on patients. The costs of OA have been
estimated to account for up to 1% to 2.5% of gross
national product (GNP) in several Western, developed
countries [1,2]. The only published cost of OA study in
Asia estimated that the cost of OA accounted for
0.28% of GNP in Hong Kong [3]. The cost of OA is
expected to remain increasing as the population ages
[4–6]. This highlights the importance of quantifying
the cost of OA for both health planning and resource
allocation.
Cost of an illness is generally divided into three
categories, namely direct, indirect, and intangible costs
[7,8]. Direct costs include all resources associated
with the provision of an intervention or treatment for
an illness. As direct costs are easily and accurately
identiﬁed and estimated [9], this cost component has
been included in many cost of OA studies [9–15]. Of
note, charges have been commonly used as a proxy for
cost in these studies as costs are often regarded as
sensitive and conﬁdential.
Indirect costs refer to productivity loss incurred by
an illness [7,8,16], and are very important in cost of
illness studies as they can be substantial. For example,
several studies have shown that estimated indirect
costs were three times higher than direct costs and
accounted for up to 80% of total costs in patients with
OA [17,18]. Conversely, some other studies suggested
that indirect costs were lower than direct costs in
OA [3,19,20]. As far as methodology is concerned,
most recently published studies used human capital
approach, which broadly encompasses both paid and
unpaid work (e.g., parenting or housekeeping) to esti-
mate indirect costs of OA by using wage rate for
absence from paid work or equivalent market price for
unpaid productivity (i.e., productivity loss of home-
makers) [3,14,15,18,19].
Intangible costs are deﬁned as pain and sufferings of
patients because of a disease, which are usually mea-
sured by using the reduction in quality of life [21,22].
Address correspondence to: Shu-Chuen Li, Discipline of Phar-
macy & Experimental Pharmacology, School of Biomedical
Sciences, University of Newcastle, Callaghan, NSW 2308, Aus-
tralia. E-mail: Shuchuen.li@newcastle.edu.au
10.1111/j.1524-4733.2008.00371.x
Volume 11 • Supplement 1 • 2008
V A L U E I N H E A L T H
S84 © 2008, International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 1098-3015/08/S84 S84–S90
Alternatively, one method of estimating the mone-
tary value of intangible costs is contingent valuation
method (CVM), a stated preference method based on
the elicitation of levels of willingness to pay (WTP),
which was ﬁrst used in measuring intangible value of
environmental improvements [23] and has increasingly
been used in health-care economics [24–30]. Neverthe-
less, it remains controversial to value intangible costs
in monetary terms as there is no real market existing.
To date, only a few studies adopted this methodology
in estimation of intangible costs in health [31–33].
Therefore, the objectives of this study are to esti-
mate indirect costs through human capital approach
and intangible costs through WTP, and identify factors
potentially affecting these costs in multiethnic Asian
patients with knee OA in Singapore.
Methods
Patient Recruitment
Patients were recruited from the Departments of Rheu-
matology and Immunology and Orthopaedic Surgery
in the Singapore General Hospital, a tertiary referral
hospital in Singapore. Prior to the face-to-face inter-
view, all patients were diagnosed with knee OA by
their attending rheumatologist or orthopedic surgeon
based on American College of Rheumatology classiﬁ-
cation criteria [34]. This was an Institutional Review
Board-approved study and written informed consent
was obtained for each patient.
Assessment of Demographic Characteristics
Patients were interviewed to obtain their demographic
and socioeconomic information by using a structured
data collection form. Patients were also asked to rate
their global well-being on a 0 mm to 100 mm visual
analog scale (VAS) anchored with worst imaginable
health state at the lowest end and best imaginable
health state at the highest end. After interview, each
patient was asked whether they have any difﬁculty in
understanding and answering these questions.
Estimation of Indirect Costs
The indirect costs were estimated using human capital
approach. All patients were asked to estimate how
many percent of productivity have been lost because of
knee OA compared with the productivity before they
had been diagnosed with OA. Additionally, working
patients were asked to estimate the number of days of
absence from work because of knee OA in the past
year. As individual wage rates were not available and
most of the patients who are still working are older
(>50 years) for whom the difference in wage rate could
be minimal, indirect costs for those who were working
were thus calculated by multiplying the number of
days of absence from work with average earnings per
capita per day in Singapore between 1993 and 2003
(i.e., S$139 per day, S$1 = US$0.6) [35], and, for
retirees/homemakers, by multiplying the percentage of
productivity loss with current market price of house-
keeping (i.e., S$280 per month). Sensitivity analysis
was performed to estimate highest indirect costs by
using the highest average earnings per capita per day in
Singapore between 1993 and 2003 (i.e., S$144) [35],
and the highest market price of housekeeping (i.e.,
S$400), while the lowest indirect costs were calculated
by using the lowest market price of housekeeping for
both working and nonworking patients (i.e., S$280
per month).
Estimation of Intangible Costs
To circumvent the difﬁculty to recruit a large number
of knee OA patients in Singapore, we chose closed-
ended iterative bidding CVM to elicit intangible costs
as it can obtain speciﬁc amount of WTP and therefore
needs a relatively small sample size [23]. In the process,
patients were provided with an initial bid and asked
whether they would like to pay this speciﬁed amount
as one-time payment in addition to their current
expenditures on treatment of OA for a hypothetical
cure of knee OA (i.e., getting rid of all pain and suf-
ferings from the disease) with 100% effectiveness and
without any side effects. If patients answered posi-
tively, then the amount was doubled. The procedure
continued until patients expressed an unwillingness
to pay the amount speciﬁed. Then the patients were
further asked to specify the maximum amount they
would like to pay between adjacent amounts to which
they said “yes” and “no” in preceding questions. If
patients answered negatively to initial bid speciﬁed,
then the amount was halved until they expressed a
WTP. Similarly, these patients were also further asked
to indicate the maximum amount they would like to
pay between adjacent amounts to which they said
“no” and “yes” in preceding questions. To minimize
the starting bid bias, patients were assigned at random
to one of three different starting bids (i.e., S$750,
S$1500, and S$3000). As no empiric data were avail-
able, the choice of these three values was based on the
annual report on earnings to represent low, middle,
and high average monthly earnings in Singapore [36].
All costs were converted to 2005 Singapore dollars by
applying 3% discount rate [23] and with equivalent
US dollars in parenthesis. As noted, intangible costs
were elicited using WTP, which are normally affected
by income (i.e., ability to pay), we hypothesized that
intangible costs will increase with higher income and
be higher for Chinese patients who generally earn
more than Malays and Indians in Singapore [35].
Additionally, higher indirect and intangible costs are
assumed to be associated with higher productivity loss
and worse global well-being of patients.
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Statistical Analyses
Kolmogorov-Smirnov test demonstrated that the
distributions of indirect and intangible costs were
skewed. A series of nonparametric univariate analyses
were therefore used. Mann–Whitney U-tests were per-
formed to identify the effects of the dichotomous
variables on indirect and intangible costs, while
Kruskal–Wallis H-tests for polytomous variables.
Separate multiple linear regression model was used to
identify the effect of a pool of variables, including age,
ethnicity, sex, working status, monthly household
income, education, comorbidities, household size, pro-
ductivity loss, and VAS score for global well-being, on
the magnitude of indirect and intangible costs. All data
were analyzed using STATA Intercooled v.8 (STATA
Corporation, College Station, TX, 2003) with a sig-
niﬁcance level of 0.05, and all tests were two-tailed.
Results
Patient Characteristics
A convenient sample of 110 eligible patients were
approached: 105 (response rate of 95.5%) agreed to
participate in this study conducted from May to
August of 2005, while ﬁve refused to participate in the
study because they thought the questions were quite
sensitive for them. All patients participated in this
study indicated they do not have any problem in
understanding these questions. Ninety-ﬁve patients
(90.5%) answered these questions without difﬁculty
compared with 10 patients with slight difﬁculty. Of
note, when answering WTP questions, three patients
(3.9%) would not like to pay for the reason that they
do not have income to spend or their OA is very mild.
Thus we considered the WTP from these three patients
as true zero rather than protest zero, and included
them in the data analysis [37,38]. As shown in Table 1,
the majority of patients were female (76.2%), married
(74.3%), ethnic Chinese (71.4%), retired or home-
makers (80.0%), or with comorbidities (66.7%).
These characteristics were similar to the general OA
patients in Singapore, where there were 75.3% female,
83.6% Chinese, and 80.8% with comorbidities [39].
Near half of the patients had been diagnosed with
knee OA for more than 5 years (46.7%), or with
the monthly household income between S$1000 to
S$2999 (US$600 to US$1799, 45.7%). The median
productivity loss was 40.0%, while the median of the
VAS score for global well-being was 70.0.
Indirect Costs
As the distribution of indirect and intangible costs
were skewed, we used median rather than mean
throughout the report. Indirect costs for each sub-
group are listed in Table 2 and summarized below.
Indirect costs for the cohort of patients in this study
were S$1680 (US$1008) per year, which accounted
for 2.8% of average annual household income [35].
Not surprisingly, the indirect costs borne by working
patients were signiﬁcantly higher than by patients
who were retired or homemakers (S$2086 vs. S$1680
[US$1252 vs. US$1008], P = 0.014). As noted, no dif-
ference in indirect costs was observed among other
variables in univariate analyses. Sensitivity analyses
demonstrated that indirect costs ranged from S$1344
to S$2160 (US$806 to US$1296), thus accounting for
2.3% to 3.6% of average annual household income,
respectively.
Intangible Costs
Intangible costs were S$2000 (US$1200) for the
cohort of patients in this study as shown in Table 2,
which accounted for 3.3% of average annual house-
hold income [35]. The intangible costs for patients
with a monthly household income above S$3000
(US$1800) were S$3000 (US$1800), compared with
S$1500 (US$900) for those with the income below
S$1000 (US$600), and S$1700 (US$1020) for those
with the income between S$1000 to S$2999 (US$600
Table 1 Characteristics of patients (n = 105)
Characteristics n (%)*
Age, years
Mean (SD) 63.6 (8.8)


















With comorbidities† 70 (66.7)
Household size
Median (IQR) 4.0 (2.0)






Median (IQR) 40.0 (25.0)
VAS score for global well-being
Median (IQR) 70.0 (20.0)
*Number with percentage in parenthesis unless otherwise speciﬁed.
†Self-reported comorbidities included hypertension (n = 46), diabetes (n = 41), high
cholesterol (n = 15), cardiovascular diseases (n = 7), cancer (n = 5), heart disease
(n = 5), asthma (n = 3), gastric ulcer (n = 2), rheumatoid arthritis (n = 2), cataract
(n = 2), ocular disease (n = 1), thyroid nodules (n = 1), and skin disease (n = 1).
SD, standard deviation; IQR, interquartile range;VAS, visual analog scale.
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to US$1799, P = 0.008). The intangible costs were
S$2900 (US$1740), S$1400 (US$840), and S$1500
(US$900) for Chinese, Malay, and Indian patients,
respectively.
Factors Inﬂuencing Indirect Costs
As shown in Table 3, the regression model with indi-
rect costs as outcome variable demonstrated that sex
and working status were the only two factors signiﬁ-
cantly affecting indirect costs (coefﬁcient = 1685.0 and
2893.4, 95% conﬁdence interval [95% CI] = 406.2–
2963.8 and 1499.6–4287.2, P = 0.010 and 0.000,
respectively). Notably, indirect costs were substantially
higher, although not attaining statistical signiﬁcance,
for Malays compared with Chinese (coefﬁcient =
1483.1, 95% CI = -93.3–3059.4, P = 0.065).
Factors Inﬂuencing Intangible Costs
In the regression model with intangible costs as
outcome variable, income attained statistical signiﬁ-
cance as expected, which supports the validity of the
WTP methodology [23]. In addition, both Malay and
Indian patients incurred less intangible costs compared
with Chinese patients (coefﬁcient = -1557.2 and
-1277.4, 95% CI = -2522.0 to -592.4 and -2247.5 to
-307.2, P = 0.002 and 0.010, respectively). Working
patients bore higher intangible costs than patients
who were retired or homemakers (coefﬁcient =
1100.5, 95% CI = 247.5–1953.6, P = 0.012). Higher
VAS score for global well-being was associated with
less intangible costs (coefﬁcient = -25.5, 95%
CI = -50.1 to -0.9, P = 0.042).
Discussion
This study estimated indirect costs per year and intan-
gible costs by using human capital approach and WTP
technique, respectively, in patients with knee OA in
Singapore. It demonstrates that these two methodolo-
gies are acceptable and feasible in this sociocultural
Table 2 Univariate analyses for indirect costs and intangible costs*
Variables N
Indirect costs† Intangible costs†
Median (IQR) P Median (IQR) P
Age 0.357 0.122
60 years 43 1680 (1378.5) 1500 (2300.0)
>60 years 62 1680 (672.0) 2950 (2500.0)
Sex 0.216 0.109
Female 80 1680 (689.3) 2700 (2500.0)
Male 25 1680 (1008.0) 1500 (2500.0)
Marital 0.994 0.805
Married 78 1680 (1106.9) 2000 (2500.0)
Others 27 1680 (504.0) 1800 (3000.0)
Ethnicity 0.500 0.059
Chinese 75 1669 (840.0) 2900 (3000.0)
Malay 15 1680 (1344.0) 1400 (2500.0)
Indian 15 1680 (938.9) 1500 (2000.0)
Education 0.343 0.207
No formal education 30 1680 (1008.0) 3000 (2000.0)
1–6 years 33 1680 (1344.0) 1400 (2250.0)
7–9 years 32 1367 (842.8) 1850 (2650.0)
10 years 10 1176 (1123.7) 2750 (2000.0)
Working status 0.014 0.355
Working 21 2086 (3198.5) 2000 (2000.0)
Retired/homemaker 84 1680 (672.0) 2000 (2100.0)
Years with OA 0.871 0.081
1 9 1344 (840.0) 2000 (3500.0)
2–3 22 1451 (1078.0) 1300 (1500.0)
4–5 25 1680 (840.0) 3000 (2600.0)
>5 49 1680 (672.0) 2500 (2000.0)
With comorbidities 0.472 0.546
Yes 70 1680 (672.0) 1900 (2100.0)
No 35 1669 (1251.6) 2900 (2500.0)
Monthly household income (S$) 0.236 0.008
<1000 29 1680 (706.5) 1500 (2500.0)
1000–2999 48 1680 (1211.0) 1700 (2000.0)
3000–4999 16 1260 (1141.5) 3000 (3300.0)
>5000 12 1344.0 (1008.0) 3000 (3250.0)
Starting bid for WTP (S$) 0.118 0.629
750 31 1344 (1008.0) 1500 (2000.0)
1500 35 1680 (1344.0) 2000 (2200.0)
3000 39 1680 (672.0) 2900 (3000.0)
Total 105 1680 (672.0) 2000 (2500.0)
*All money were quoted in 2005 Singapore dollars, S$1 = US$0.6, and indirect costs were estimated on a 1-year basis of 2005.
†Mann–Whitney U-test and Kruskal–Wallis H-test were used for dichotomous and polytomous variables, respectively.
IQR, interquartile range; OA, osteoarthritis;WTP, willingness-to-pay.
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context. Moreover, the quantiﬁcation of these two cost
components has important implications in health-care
delivery and planning. First, it can speciﬁcally contrib-
ute to better and comprehensive understanding of the
economic burden of knee OA. This study conﬁrmed
that the economic burden incurred by knee OA would
be substantial besides direct costs. Ignoring these two
important cost components would therefore signiﬁ-
cantly underestimate the true burden of this chronic
condition. Second, indirect and intangible costs of
knee OA estimated in this study could be compared
with the costs of other chronic conditions such as
rheumatoid arthritis and hypertension [20]. This kind
of comparison would provide useful information for
governmental decision-makers in allocation of ﬁnite
health resources. It is worth noting that to the best of
our knowledge, this is one of the ﬁrst studies to quan-
tify intangible costs in monetary terms. As intangible
costs were elicited using WTP, which can inversely be
considered as a beneﬁt from an effective health-care
program for knee OA, it also helps pharmaceutical
companies or health maintenance organizations to
make a decision on developing a new treatment or
health program for knee OA.
In this study, indirect costs of knee OA estimated in
this study are comparable with those in other coun-
tries. The indirect costs estimated accounted for 2.3%
(US$1175) of average annual household income in
the United States [19,40], 3.0% (US$2040) in Canada
[20,41], 4.0% (US$904) in Hong Kong [3], 4.7%
(US$1981) in Italy [18,42]. Although certain variation
in absolute magnitudes of indirect costs was observed
across countries, relative magnitudes of indirect costs
in terms of percentage of average annual household
income were within the range of 2% to 5% across
these countries. As the comparison is based on differ-
ent studies applying the same methodology (i.e.,
human capital approach) among different populations
across several continents (i.e., Europe, North America,
and Asia), this ﬁnding implies that it might be viable
to use this percentage range to quickly and approxi-
mately estimate indirect costs of OA in other countries
around the world.
Nevertheless, it should be noted that another
study also done in Canada [17] estimated that indi-
rect costs accounted for 17.9% (US$11,497) of
average annual household income. The main reason
for the variation is that Gupta et al. used aver-
age monthly wage rate of US$1278 for professional
homemakers, which is signiﬁcantly higher than the
wage rates used in other studies. The indirect costs
will be increased to account for 18.6% of average
annual household income if we use this wage rate in
the estimation in our study.
In contrast, intangible costs were generally mea-
sured using reduction in quality of life [21,22]. As few
studies are using WTP to quantify intangible costs, it is
difﬁcult to make a systematic comparison. In the very
few published studies which quantiﬁed these costs in
monetary terms, CVM was also used to elicit WTP
as a proxy for intangible costs. The intangible costs
accounted for 3.0% (US$1387) of average annual
household income for sharp-related injuries in the
United States [31], and 0.42% (US$193 per year) for
urinary storage symptoms in the UK [33]. Addition-
ally, several observations in estimating intangible costs
are worth noting. First, the starting bid bias is known
as one of the major limitations when applying closed-
ended iterative bidding CVM in eliciting WTP [37].
Nevertheless, the inﬂuence is not statistically signiﬁ-
cant in this study, although there is a slightly increased
intangible costs (i.e., WTP) associated with larger
starting bid (Table 2). Second, intangible costs for the
patients with better health status (i.e., higher VAS
scores for global well-being) were less than the costs
for those with worse health status. We expected that
Table 3 Multiple linear regression analyses for indirect and intangible costs
Independent variables
Dependent variables
Indirect costs Intangible costs
Coefﬁcients (95% CI) P Coefﬁcients (95% CI) P
Age (per year) 6.92 (-56.37, 70.21) 0.829 10.63 (-28.11, 49.36) 0.587
Malay* 1483.05 (-93.30, 3059.39) 0.065 -1557.17 (-2521.95, -592.40) 0.002
India* 680.88 (-904.26, 2262.02) 0.396 -1277.36 (-2247.50, -307.20) 0.010
Male 1685.00 (406.18, 2963.82) 0.010 -407.91 (-1190.59, 374.76) 0.303
Working patients† 2893.38 (1499.58, 4287.18) 0.000 1100.51 (247.46, 1953.56) 0.012
Income (per dollar) 0.07 (-0.19, 0.34) 0.591 0.28 (0.12, 0.44) 0.001
Education (per year) -79.78 (-178.37, 18.81) 0.111 55.69 (-4.65, 116.03) 0.070
With comorbidities‡ 241.64 (-874.76, 1358.03) 0.668 -383.05 (-1066.32, 300.22) 0.268
Household size (per person) -285.49 (-650.75, 79.78) 0.124 -88.23 (-311.78, 135.32) 0.435
Productivity loss (per percentage) 28.90 (-1.75, 59.56) 0.064 13.00 (-5.76, 31.76) 0.172
VAS score for global wellbeing (per unit, range, 0–100) 22.66 (-17.54, 62.87) 0.266 -25.51 (-50.12, -0.90) 0.042
*The reference group is Chinese.
†The reference group are retirees and homemakers.
‡The reference group is without comorbidity.
95% CI, 95% conﬁdence interval;VAS, visual analog scale.
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both the productivity loss because of knee OA and
global well-being should be associated with intangible
costs. Nevertheless, a signiﬁcant relationship between
productivity loss and intangible costs was not observed
in this study. As most of the patients (70 of 105) were
diagnosed with comorbidities, it might be very difﬁcult
for them to distinguish the pain and sufferings from
OA and other diseases. Therefore, intangible costs
might be overestimated in this study, as the costs could
not be exclusively attributable to knee OA. This issue
might be addressed by comparing the intangible costs
incurred by knee OA patients with the control patient
group without the disease [11]. As noted, the substan-
tial ethnic differences in intangible costs persisted
with adjustment for other demographic variables. This
observation might be explained by the tradition that
Chinese patients thought arthritis is a natural process
for the elderly, which make them reluctant to see a
doctor at the early stage of the disease (personal com-
munications with patients). Thus, most Chinese
patients seen in the hospital were quite severe and
consequently bore higher intangible costs.
One of the major limitations of this study is that the
productivity loss incurred by family members or car-
egivers was not assessed, as most of the patients in this
study reported that they did not recall such informa-
tion at all. Thus, the magnitude of indirect costs esti-
mated in this study could be considered as at a lower
end of the spectrum. A suggestion for further reﬁne-
ment would be to include the indirect costs borne by
the caregivers in future study [16]. Additionally, the
number of days of absence was estimated based on
the recall of patients, which might not be accurate.
Nevertheless, the clinicians were also approached to
obtain more accurate estimation. Second, the impact
of comorbidities on cost estimation was not assessed in
this study, which will limit the comprehensive evalua-
tion of the economic burden of OA on patients with
comorbidities compared with those without any
comorbidity. Finally, because of the limitation in
number of patients with other types of OA, we cannot
recruit these patients in this study. Nevertheless, it is
worth noting that estimating indirect and intangible
costs for other types of OA is necessary, which can
contribute to comprehensive evaluation of the eco-
nomic burden of OA.
In conclusion, this study demonstrated that eliciting
indirect costs through the human capital approach and
intangible costs through the WTP are acceptable and
feasible in Asian patients with knee OA. Our study
also estimated that indirect and intangible costs for the
patients with knee OA could be substantial.
The authors thank Chong Hwee Chi, William Yeo, Li Wei,
and Dorothy Tai in the Orthopaedic Diagnostic Center of
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